perioperative management of glp-1 agonists How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Patients on Glucagon-Like Peri-op management of adults taking
Description
Dose adjustments are probably not required for simultaneous use of GLP1RAs with oral medications

About a quarter of non-carriers reached the recommended HbA1c target after six months of treatment, compared with 11.5% of participants with the p.S539W variant and 18.5% of participants with the p.D563G variant

Rationally designed dendritic silica nanoparticles for oral delivery of exenatide

Novo puts $285m into monthly GLP-1 based on Ascendis tech Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist

To start, Semaglutide GLP-1 is only recommended for those who are over 21 years of age and who have a body mass index (BMI) over 27
